Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming

The majority of breast cancers expresses the estrogen receptor (ER(+)) and is treated with anti-estrogen therapies, particularly tamoxifen in premenopausal women. However, tamoxifen resistance is responsible for a large proportion of breast cancer deaths. Using small molecule inhibitors, phospho-mim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Genes Dev
Autors principals: Geter, Phillip A., Ernlund, Amanda W., Bakogianni, Sofia, Alard, Amandine, Arju, Rezina, Giashuddin, Shah, Gadi, Abhilash, Bromberg, Jacqueline, Schneider, Robert J.
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory Press 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5769768/
https://ncbi.nlm.nih.gov/pubmed/29269484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.305631.117
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars